Generation and functional characterization of motor neurons derived through transcription factor mediated programming of human pluripotent stem cells

Focusing on ioMotor Neurons | Human iPSC-derived motor neurons for clump-free cell culture

Harnessing CRISPR-ready ioGlutamatergic neurons for drug discovery in neurodegenerative diseases

Focusing on CRISPR-Ready ioGlutamatergic Neurons | Human iPSC-derived glutamatergic neurons expressing Cas9 for rapid gene knockout generation

A toolbox of human iPSC-derived microglia in different genetic backgrounds and disease models for neurodegeneration drug discovery

Focusing on female and male ioMicroglia | Female and male human iPSC donor-derived microglia

Advancing drug discovery: Leveraging CRISPR-ready iomicroglia for functional genomics studies

Focusing on CRISPR-ReadyioMicroglia | Male human iPSC donor-derived microglia expressing Cas9 for rapid gene knockout generation

Scalable and well defined human glutamatergic and GABAergic co-culture platform suitable for studying excitatory inhibitory neuron imbalances and the discovery of drugs to treat associated diseases

Focusing on tri-culture of Glutamatergic Neurons, GABAergic Neurons and astrocytes for MEA assays

Scalable iPSC programming strategy in combination with optimized cocktails of neurotrophic factors yields functionally distinct nociceptor sensory neurons

Focusing on ioSensory Neurons | Highly pure human iPSC-derived sensory neurons with a defined nociceptor identity

Generation of human iPSC-derived Duchenne muscular dystrophy skeletal myocytes suitable for 3D functional studies and investigating methods for dystrophin restoration

Focusing on ioSkeletal Myocytes | Human iPSC-derived skeletal myocytes

Physiologically relevant media unmasks severe mitochondrial dysfunction in a precision reprogrammed iPSC-derived model of Huntington’s disease

Focusing on ioGlutamatergic NeuronsHTT 50CAG/WT | Human iPSC‑derived Huntington’s disease model